We hypothesized that higher levels of AD/ADRD BBMs, specifically NfL and GFAP, would be associated with higher depressive symptoms, and that these associations would be stronger for women and APOE ε4 carriers compared to men and non‐carriers, respectively. This evidence concerns the gene GFAP and Alzheimer disease.